- Home
- TECH
TECH
Bio-Techne Corp
as 11-26-2025 3:37pm EST
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.
| Founded: | 1976 | Country: | United States |
| Employees: | N/A | City: | MINNEAPOLIS |
| Market Cap: | 8.9B | IPO Year: | 1989 |
| Target Price: | $71.23 | AVG Volume (30 days): | 2.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 0.49 | EPS Growth: | -48.73 |
| 52 Week Low/High: | $46.01 - $79.28 | Next Earning Date: | 11-05-2025 |
| Revenue: | $1,216,732,000 | Revenue Growth: | 3.85% |
| Revenue Growth (this year): | 3.64% | Revenue Growth (next year): | 7.59% |
Latest Bio-Techne Corp News
TECH Breaking Stock News: Dive into TECH Ticker-Specific Updates for Smart Investing
Simply Wall St.
7 days ago
Exclusive AI-Designed Protein Access Might Change the Case for Investing in Bio-Techne (TECH)
MT Newswires
7 days ago
Argus Adjusts Price Target on Bio-Techne to $68 From $65, Maintains Buy Rating
Argus Research
7 days ago
Analyst Report: Bio-Techne Corp
Argus Research
7 days ago
Market Digest: ACM, NVDA, TECH, DLR, KHC, HUBS
PR Newswire
9 days ago
Bio-Techne Licenses AI-Designed NovoBody™ Duo Molecules from Monod Bio to Expand Recombinant Protein Portfolio
Investor's Business Daily
2 months ago
S&P 500 Stocks: These 5 Lead As Index Hits Record High
StockStory
2 months ago
Centene, QuidelOrtho, iRhythm, and Bio-Techne Shares Skyrocket, What You Need To Know
Simply Wall St.
2 months ago
Could Spatial Biology Advances Shape Bio-Techne's (TECH) Long-Term Position in Precision Medicine?
Compare TECH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "TECH Bio-Techne Corp - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.